Rana, Dikshyanta http://orcid.org/0000-0001-9133-3094
Geue, Claudia
Baillie, Kelly
Pan, Jiafeng
Mueller, Tanja
Laskey, Jennifer
Bennie, Marion
Clarke, Julie
Jones, Robert J.
Brown, Ailsa
Wu, Olivia
Funding for this research was provided by:
Scottish Government
Article History
Accepted: 29 September 2021
First Online: 10 November 2021
Declarations
:
: This work was supported by the Scottish Government. The funder had no role in the study design, data collection, data analysis, or interpretation of the data, or in the preparation, review, or approval of the manuscript for publication.
: All authors declare no support from any organisations for the submitted work. CG has received research funding from BMS Pfizer and Novo Nordisk, not related to this work. RJ reports he has received research funding, speaker honoraria, and consultancy fees from Astellas relating to enzalutamide and from Janssen relating to abiraterone. RJ has received consultancy fees from Janssen relating to other products not related to the work. RJ has received consultancy fees from Astellas relating to other products not related to the work. The other authors declare no competing interests.
: The CMOP management group are unable to share the raw data. Permission to view patient-level data needs to come from the UK Caldicott Guardian Council.
: Available on request. Relevant permission, as mentioned for availability of data, needs to be obtained.
: All authors approve the final version. The authors contributed to this research study as follows: DR: conceptualisation, data curation, performed the analysis, interpretation, manuscript (writing, editing and reviewing); CG: conceptualisation, supervised the analysis, interpretation, manuscript (editing and reviewing); JP and TM: data linkage, interpretation, manuscript (reviewing); KB, JC, JL, MB, RJ, and AB: interpretation, manuscript (reviewing); OW: conceptualisation, supervised the analysis, interpretation, manuscript (editing and reviewing)
: This was an observational study, so ethics approval was not required. However, the use of the data was approved by the Local Privacy Advisory Committee.
: Not applicable.